Ranbaxy gets USFDA nod for to sell muscle relaxing tabs in US
Home-grown pharma major, Ranbaxy has received the US Food and Drug Administration's (USFDA) approval for selling cyclobenzaprine hydrochloride tablets used as muscle relaxant in different strengths in the US markets.
The company has got the approval of USFDA to launch cyclobenzaprine hydrochloride in 5mg, 7.5 mg and 10 mg strengths, according to the information available on the website of USFDA.
Ranbaxy is a leading domestic drug manufacturer and the company has the largest number of USFDA approved drugs.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.